Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, side effects from Mounjaro arrive within the first day or two after the initial injection, with nausea being the most commonly reported. They tend to peak in the days immediately after each dose, particularly at the start of treatment or following a dose increase, and often ease within one to two weeks as the body adjusts. These are prescription-only medicines assessed individually by a prescriber — whether they're the right fit for you depends on your full medical picture, not just your weight. The real question most people are weighing up is: if something does happen, how quickly, and how bad? The honest answer follows.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, it acts on two gut-hormone pathways that regulate appetite and slow how quickly the stomach empties. That slowing is directly behind the most common early experience: a rolling queasiness that can feel like mild motion sickness, sometimes accompanied by bloating or an urge to burp. If you want to understand how quickly Mounjaro side effects tend to appear, it usually begins within a day of the first injection.
A common misconception is that strong early nausea means Mounjaro is working particularly well, or conversely that no nausea means it isn't. Neither is true. The intensity varies considerably between individuals and has no reliable relationship to how much weight someone will lose. Some people feel nothing at all after the first pen; others spend two or three days picking at plain food. Both are normal.
The NHS tirzepatide medicines page lists the most frequently reported effects: nausea, vomiting, diarrhoea, constipation, stomach discomfort, and fatigue. Headache and dizziness appear too, though less often. Injection-site redness or itching is possible and typically brief. The 2.5 mg starting dose exists precisely to give the body time to adjust before any increase, it's a tolerability measure, not a treatment target. Our prescribers at our Mounjaro overview can explain the titration logic in the context of your own history.
Staying well hydrated helps considerably. Small, frequent meals tend to cause less discomfort than larger ones during the first week.
For many people, the first dose is the hardest. As the dose steps up (typically every four weeks, though timing is always the prescriber's call), a milder version of those early symptoms can return for a few days before settling again. The body has already adapted to the drug class; what it's recalibrating to is the higher level.
This pattern is documented across the SURMOUNT clinical trial programme and reflected in the prescribing information. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found that gastrointestinal side effects were the most common reason participants reduced or paused doses, not stopped treatment entirely. Those wondering how quickly Mounjaro side effects kick in at each new dose step will find that the pattern typically mirrors the initial experience, though it tends to be shorter-lived as the body becomes more familiar with the medicine.
Practical things that tend to help: eating slowly, avoiding very fatty or spicy meals around injection day, and not eating to fullness when appetite is already reduced. If symptoms at a dose step are severe or don't ease within two weeks, a prescriber should know, holding at the current dose is a clinically recognised option. Details on the full side-effect picture are on our Mounjaro side effects page, and questions about your specific situation can be raised through our support team.
Anyone curious about whether the timing of effects differs between starting doses can find more detail on how quickly Mounjaro side effects start.
Most of what Mounjaro causes is unpleasant but not dangerous. A handful of signs are different and warrant same-day or emergency medical contact.
The most important is severe, persistent abdominal pain, particularly pain that spreads to the back, with or without vomiting. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis: a rare but serious risk that requires urgent assessment if those symptoms appear. This is not a reason to avoid treatment; it's a reason to know the symptom. Seek urgent care immediately if it occurs.
Other signs that need prompt attention: symptoms of a serious allergic reaction (facial swelling, difficulty breathing, a widespread rash); signs of severe dehydration from prolonged vomiting or diarrhoea (dizziness on standing, very dark urine, inability to keep fluids down); and symptoms consistent with gallbladder problems, such as pain under the right ribs, fever, or jaundice. The NHS tirzepatide information covers these in full.
If you experience anything that concerns you and you're not sure it's urgent, our prescribers are reachable through our FAQs or via the support page, we offer priority aftercare seven days a week. For anything urgent, call 111 or attend A&E. Suspected side effects, including any not listed in the patient leaflet, can be reported directly to the MHRA via the Yellow Card scheme.
Knowing the timing (likely within two days, usually settled within two weeks, briefly repeating at each increase) helps you plan practically rather than brace nervously. Most people starting Mounjaro find the first fortnight the most demanding, and a significant proportion find it barely noticeable at the starter dose.
The decision about whether the benefit-risk balance makes sense for you is one a prescriber makes with you, not for you. At nume, every consultation is read personally by a GPhC-registered Independent Prescriber the same day, a real clinician who can discuss your medical history, any medicines you're already taking, and what to watch for. Our clinical team takes a thorough approach because the detail matters.
If you're weighing up the broader picture before starting, the full breakdown of known Mounjaro side effects covers what the evidence shows across the trial programme. And if cost is part of your thinking, our guide to Mounjaro pricing in the UK explains what to look for in a legitimate provider. When you're ready, you can start your free consultation and have your questions answered properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.